Cannabis Science, Inc. (OTCMKTS:CBIS) COO Robert James Kane sold 198,820 shares of Cannabis Science stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $0.06, for a total value of $11,929.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Cannabis Science, Inc. (OTCMKTS:CBIS) remained flat at $$0.05 during trading on Thursday. The stock had a trading volume of 16,382,972 shares, compared to its average volume of 17,190,000. Cannabis Science, Inc. has a twelve month low of $0.03 and a twelve month high of $0.14.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.thelincolnianonline.com/2017/12/07/insider-selling-cannabis-science-inc-cbis-coo-sells-11929-20-in-stock.html.
About Cannabis Science
Cannabis Science, Inc is engaged in medical marijuana research and development. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. The Company is involved in the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Receive News & Ratings for Cannabis Science Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabis Science Inc. and related companies with MarketBeat.com's FREE daily email newsletter.